The 'non-falciparum' malarias: the roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies

Plasmodium vivax, P. ovale, P. malariae and P. falciparum routinely infect humans. The infections caused by these parasites are loosely referred to as vivax (or benign tertian), ovale, malariae (or quartan) and falciparum (or malignant tertian) malaria, respectively. Recently, P. knowlesi, a parasit...

Full description

Saved in:
Bibliographic Details
Published in:Annals of tropical medicine and parasitology 2010-06, Vol.104 (4), p.283-301
Main Authors: Maguire, J. D., Baird, J. K.
Format: Article
Language:English
Subjects:
Animals
Antimalarials - therapeutic use
Biological and medical sciences
General aspects
Human protozoal diseases
Humans
Infectious diseases
Macaca
Malaria
Malaria - drug therapy
Malaria - epidemiology
Malaria - parasitology
Medical sciences
Parasitic diseases
Plasmodium - physiology
Plasmodium falciparum
Plasmodium vivax
Protozoal diseases
Secondary Prevention
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c436t-29fff1143c60116d19671caff4087df1d5fa95d92809a0807c979ab73c5d1acd3
cites cdi_FETCH-LOGICAL-c436t-29fff1143c60116d19671caff4087df1d5fa95d92809a0807c979ab73c5d1acd3
container_end_page 301
container_issue 4
container_start_page 283
container_title Annals of tropical medicine and parasitology
container_volume 104
creator Maguire, J. D.
Baird, J. K.
description Plasmodium vivax, P. ovale, P. malariae and P. falciparum routinely infect humans. The infections caused by these parasites are loosely referred to as vivax (or benign tertian), ovale, malariae (or quartan) and falciparum (or malignant tertian) malaria, respectively. Recently, P. knowlesi, a parasite of macaque monkeys in South-east Asia, has been identified as the cause of uncomplicated and severe human malaria in Malaysian Borneo. The prescription of appropriate therapies for reliably diagnosed malaria requires a grasp of the epidemiology of the 'non-falciparum' malarias, the biology of the parasites involved, the chemotherapeutic strategies that are available and the problems of emerging drug resistance and changing clinical syndromes. This review is intended to increase clinicians' understanding of how these factors relate to the selection of the antimalarial drugs to be given to a case of 'non-falciparum' malaria, with the aims of improving outcomes and preventing relapses and recrudescences.
doi_str_mv 10.1179/136485910X12743554760027
format article
fullrecord <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_23019832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>899167183</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-29fff1143c60116d19671caff4087df1d5fa95d92809a0807c979ab73c5d1acd3</originalsourceid><addsrcrecordid>eNqFkc-KFDEQxoMo7uzqK0guMhdbk0660_Emg7rCgpcVvDU1-dNG0kmbpFnmgXxPM8yMnmRPIfX9vqqiPoQwJW8pFfIdZT0fOknJd9oKzrqOi56QVjxBm6PUVI0_RRtCCGu4HNgVus75Z_22PeHP0VVL-k4ySTbo9_0Pg7chhsaCV26BtM5bPIOH5CC_x6XKKXqTcbTYLE6b2UUfp8MbXFnIrhi8v1SUd8Ep8Dgfgk5xNrnW4rz4WiwuhowhaKwdTCHm4hROboprwi7gaXXahek4L8Fi1qOaS4JiJmfyC_SsrpfNy_N7g759-ni_u23uvn7-svtw1yjO-tK00lpLKWeqJ5T2mspeUAXWcjIIbanuLMhOy3YgEshAhJJCwl4w1WkKSrMbtD31XVL8tZpcxtllZbyHYOKax0FKWlsO7FFSME4Y5aSv5HAiVYo5J2PHJbkZ0mGkZDymOf4vzWp9dR6y7mej_xov8VXg9RmAXO9uEwTl8j-OEVrTbyu3O3Eu2JhmeIjJ67HAwcd0MbFH1_kDavO_kg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734031406</pqid></control><display><type>article</type><title>The 'non-falciparum' malarias: the roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Maguire, J. D. ; Baird, J. K.</creator><creatorcontrib>Maguire, J. D. ; Baird, J. K.</creatorcontrib><description>Plasmodium vivax, P. ovale, P. malariae and P. falciparum routinely infect humans. The infections caused by these parasites are loosely referred to as vivax (or benign tertian), ovale, malariae (or quartan) and falciparum (or malignant tertian) malaria, respectively. Recently, P. knowlesi, a parasite of macaque monkeys in South-east Asia, has been identified as the cause of uncomplicated and severe human malaria in Malaysian Borneo. The prescription of appropriate therapies for reliably diagnosed malaria requires a grasp of the epidemiology of the 'non-falciparum' malarias, the biology of the parasites involved, the chemotherapeutic strategies that are available and the problems of emerging drug resistance and changing clinical syndromes. This review is intended to increase clinicians' understanding of how these factors relate to the selection of the antimalarial drugs to be given to a case of 'non-falciparum' malaria, with the aims of improving outcomes and preventing relapses and recrudescences.</description><identifier>ISSN: 0003-4983</identifier><identifier>EISSN: 1364-8594</identifier><identifier>DOI: 10.1179/136485910X12743554760027</identifier><identifier>PMID: 20659390</identifier><identifier>CODEN: ATMPA2</identifier><language>eng</language><publisher>Leeds: Taylor &amp; Francis</publisher><subject>Animals ; Antimalarials - therapeutic use ; Biological and medical sciences ; General aspects ; Human protozoal diseases ; Humans ; Infectious diseases ; Macaca ; Malaria ; Malaria - drug therapy ; Malaria - epidemiology ; Malaria - parasitology ; Medical sciences ; Parasitic diseases ; Plasmodium - physiology ; Plasmodium falciparum ; Plasmodium vivax ; Protozoal diseases ; Secondary Prevention</subject><ispartof>Annals of tropical medicine and parasitology, 2010-06, Vol.104 (4), p.283-301</ispartof><rights>2010 Maney Publishing 2010</rights><rights>2015 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-29fff1143c60116d19671caff4087df1d5fa95d92809a0807c979ab73c5d1acd3</citedby><cites>FETCH-LOGICAL-c436t-29fff1143c60116d19671caff4087df1d5fa95d92809a0807c979ab73c5d1acd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23019832$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20659390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maguire, J. D.</creatorcontrib><creatorcontrib>Baird, J. K.</creatorcontrib><title>The 'non-falciparum' malarias: the roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies</title><title>Annals of tropical medicine and parasitology</title><addtitle>Ann Trop Med Parasitol</addtitle><description>Plasmodium vivax, P. ovale, P. malariae and P. falciparum routinely infect humans. The infections caused by these parasites are loosely referred to as vivax (or benign tertian), ovale, malariae (or quartan) and falciparum (or malignant tertian) malaria, respectively. Recently, P. knowlesi, a parasite of macaque monkeys in South-east Asia, has been identified as the cause of uncomplicated and severe human malaria in Malaysian Borneo. The prescription of appropriate therapies for reliably diagnosed malaria requires a grasp of the epidemiology of the 'non-falciparum' malarias, the biology of the parasites involved, the chemotherapeutic strategies that are available and the problems of emerging drug resistance and changing clinical syndromes. This review is intended to increase clinicians' understanding of how these factors relate to the selection of the antimalarial drugs to be given to a case of 'non-falciparum' malaria, with the aims of improving outcomes and preventing relapses and recrudescences.</description><subject>Animals</subject><subject>Antimalarials - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>General aspects</subject><subject>Human protozoal diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Macaca</subject><subject>Malaria</subject><subject>Malaria - drug therapy</subject><subject>Malaria - epidemiology</subject><subject>Malaria - parasitology</subject><subject>Medical sciences</subject><subject>Parasitic diseases</subject><subject>Plasmodium - physiology</subject><subject>Plasmodium falciparum</subject><subject>Plasmodium vivax</subject><subject>Protozoal diseases</subject><subject>Secondary Prevention</subject><issn>0003-4983</issn><issn>1364-8594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFkc-KFDEQxoMo7uzqK0guMhdbk0660_Emg7rCgpcVvDU1-dNG0kmbpFnmgXxPM8yMnmRPIfX9vqqiPoQwJW8pFfIdZT0fOknJd9oKzrqOi56QVjxBm6PUVI0_RRtCCGu4HNgVus75Z_22PeHP0VVL-k4ySTbo9_0Pg7chhsaCV26BtM5bPIOH5CC_x6XKKXqTcbTYLE6b2UUfp8MbXFnIrhi8v1SUd8Ep8Dgfgk5xNrnW4rz4WiwuhowhaKwdTCHm4hROboprwi7gaXXahek4L8Fi1qOaS4JiJmfyC_SsrpfNy_N7g759-ni_u23uvn7-svtw1yjO-tK00lpLKWeqJ5T2mspeUAXWcjIIbanuLMhOy3YgEshAhJJCwl4w1WkKSrMbtD31XVL8tZpcxtllZbyHYOKax0FKWlsO7FFSME4Y5aSv5HAiVYo5J2PHJbkZ0mGkZDymOf4vzWp9dR6y7mej_xov8VXg9RmAXO9uEwTl8j-OEVrTbyu3O3Eu2JhmeIjJ67HAwcd0MbFH1_kDavO_kg</recordid><startdate>20100601</startdate><enddate>20100601</enddate><creator>Maguire, J. D.</creator><creator>Baird, J. K.</creator><general>Taylor &amp; Francis</general><general>Maney</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>C1K</scope><scope>F1W</scope><scope>H95</scope><scope>H97</scope><scope>L.G</scope><scope>M7N</scope></search><sort><creationdate>20100601</creationdate><title>The 'non-falciparum' malarias: the roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies</title><author>Maguire, J. D. ; Baird, J. K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-29fff1143c60116d19671caff4087df1d5fa95d92809a0807c979ab73c5d1acd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Antimalarials - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>General aspects</topic><topic>Human protozoal diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Macaca</topic><topic>Malaria</topic><topic>Malaria - drug therapy</topic><topic>Malaria - epidemiology</topic><topic>Malaria - parasitology</topic><topic>Medical sciences</topic><topic>Parasitic diseases</topic><topic>Plasmodium - physiology</topic><topic>Plasmodium falciparum</topic><topic>Plasmodium vivax</topic><topic>Protozoal diseases</topic><topic>Secondary Prevention</topic><toplevel>online_resources</toplevel><creatorcontrib>Maguire, J. D.</creatorcontrib><creatorcontrib>Baird, J. K.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 3: Aquatic Pollution &amp; Environmental Quality</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Annals of tropical medicine and parasitology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maguire, J. D.</au><au>Baird, J. K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The 'non-falciparum' malarias: the roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies</atitle><jtitle>Annals of tropical medicine and parasitology</jtitle><addtitle>Ann Trop Med Parasitol</addtitle><date>2010-06-01</date><risdate>2010</risdate><volume>104</volume><issue>4</issue><spage>283</spage><epage>301</epage><pages>283-301</pages><issn>0003-4983</issn><eissn>1364-8594</eissn><coden>ATMPA2</coden><abstract>Plasmodium vivax, P. ovale, P. malariae and P. falciparum routinely infect humans. The infections caused by these parasites are loosely referred to as vivax (or benign tertian), ovale, malariae (or quartan) and falciparum (or malignant tertian) malaria, respectively. Recently, P. knowlesi, a parasite of macaque monkeys in South-east Asia, has been identified as the cause of uncomplicated and severe human malaria in Malaysian Borneo. The prescription of appropriate therapies for reliably diagnosed malaria requires a grasp of the epidemiology of the 'non-falciparum' malarias, the biology of the parasites involved, the chemotherapeutic strategies that are available and the problems of emerging drug resistance and changing clinical syndromes. This review is intended to increase clinicians' understanding of how these factors relate to the selection of the antimalarial drugs to be given to a case of 'non-falciparum' malaria, with the aims of improving outcomes and preventing relapses and recrudescences.</abstract><cop>Leeds</cop><pub>Taylor &amp; Francis</pub><pmid>20659390</pmid><doi>10.1179/136485910X12743554760027</doi><tpages>19</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-4983
ispartof Annals of tropical medicine and parasitology, 2010-06, Vol.104 (4), p.283-301
issn 0003-4983
1364-8594
language eng
recordid cdi_pascalfrancis_primary_23019832
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Animals
Antimalarials - therapeutic use
Biological and medical sciences
General aspects
Human protozoal diseases
Humans
Infectious diseases
Macaca
Malaria
Malaria - drug therapy
Malaria - epidemiology
Malaria - parasitology
Medical sciences
Parasitic diseases
Plasmodium - physiology
Plasmodium falciparum
Plasmodium vivax
Protozoal diseases
Secondary Prevention
title The 'non-falciparum' malarias: the roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T19%3A07%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20'non-falciparum'%20malarias:%20the%20roles%20of%20epidemiology,%20parasite%20biology,%20clinical%20syndromes,%20complications%20and%20diagnostic%20rigour%20in%20guiding%20therapeutic%20strategies&rft.jtitle=Annals%20of%20tropical%20medicine%20and%20parasitology&rft.au=Maguire,%20J.%20D.&rft.date=2010-06-01&rft.volume=104&rft.issue=4&rft.spage=283&rft.epage=301&rft.pages=283-301&rft.issn=0003-4983&rft.eissn=1364-8594&rft.coden=ATMPA2&rft_id=info:doi/10.1179/136485910X12743554760027&rft_dat=%3Cproquest_pasca%3E899167183%3C/proquest_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c436t-29fff1143c60116d19671caff4087df1d5fa95d92809a0807c979ab73c5d1acd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=734031406&rft_id=info:pmid/20659390&rfr_iscdi=true